Mitchell Kapoor
Stock Analyst at H.C. Wainwright
(4.00)
# 1,769
Out of 5,081 analysts
830
Total ratings
36%
Success rate
5.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Reiterated: Buy | $152 | $113.31 | +34.15% | 26 | Oct 27, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $120 | $90.33 | +32.85% | 21 | Oct 27, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $100 | $43.42 | +130.31% | 37 | Oct 26, 2026 | |
| KYTX Kyverna Therapeutics | Reiterated: Buy | $25 | $5.27 | +374.38% | 24 | Oct 26, 2026 | |
| LYEL Lyell Immunopharma | Reiterated: Buy | $45 | $9.31 | +383.35% | 27 | Oct 26, 2026 | |
| AVTX Avalo Therapeutics | Downgraded: Hold | $30 | $6.77 | +343.13% | 10 | Oct 23, 2026 | |
| KRRO Korro Bio | Reiterated: Buy | $15 | $12.02 | +24.79% | 26 | Oct 23, 2026 | |
| PALI Palisade Bio | Reiterated: Buy | $7 | $1.23 | +469.11% | 8 | Oct 23, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Hold | n/a | $14.50 | - | 42 | Oct 23, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $344 | $245.15 | +40.32% | 5 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $12.76 | +182.13% | 11 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $20.39 | +218.78% | 67 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $17.98 | -72.19% | 37 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $128.01 | +1.55% | 64 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $12.35 | +142.91% | 7 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $49.01 | +63.23% | 20 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $6.51 | +130.41% | 26 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.13 | - | 10 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $10.48 | +138.55% | 2 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $6.28 | +298.09% | 25 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $29 | $20.42 | +42.02% | 39 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 | $55.75 | +7.62% | 16 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 575.00 | kr 459.00 | +25.27% | 9 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $11.26 | +122.02% | 17 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $15.60 | +284.62% | 2 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $9.18 | +117.86% | 5 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $8.05 | +210.56% | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.42 | +252.11% | 29 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $65 | $23.54 | +176.13% | 35 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $21.26 | +111.67% | 4 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.40 | +108.33% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $11 | $2.23 | +394.38% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $10 | $2.70 | +270.37% | 16 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.57 | - | 20 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.41 | n/a | 3 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.7674 | n/a | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $3.56 | n/a | 9 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $6.07 | n/a | 1 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $16.65 | n/a | 26 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0003 | n/a | 16 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.6172 | n/a | 24 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $4.31 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $2.48 | n/a | 6 | May 14, 2024 |
Incyte
Oct 27, 2026
Reiterated: Buy
Price Target: $152
Current: $113.31
Upside: +34.15%
Oruka Therapeutics
Oct 27, 2026
Reiterated: Buy
Price Target: $120
Current: $90.33
Upside: +32.85%
Ionis Pharmaceuticals
Oct 26, 2026
Reiterated: Buy
Price Target: $100
Current: $43.42
Upside: +130.31%
Kyverna Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $25
Current: $5.27
Upside: +374.38%
Lyell Immunopharma
Oct 26, 2026
Reiterated: Buy
Price Target: $45
Current: $9.31
Upside: +383.35%
Avalo Therapeutics
Oct 23, 2026
Downgraded: Hold
Price Target: $30
Current: $6.77
Upside: +343.13%
Korro Bio
Oct 23, 2026
Reiterated: Buy
Price Target: $15
Current: $12.02
Upside: +24.79%
Palisade Bio
Oct 23, 2026
Reiterated: Buy
Price Target: $7
Current: $1.23
Upside: +469.11%
Summit Therapeutics
Oct 23, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.50
Upside: -
Ascendis Pharma
Oct 19, 2026
Reiterated: Buy
Price Target: $344
Current: $245.15
Upside: +40.32%
Oct 19, 2026
Reiterated: Buy
Price Target: $36
Current: $12.76
Upside: +182.13%
Oct 19, 2026
Reiterated: Buy
Price Target: $65
Current: $20.39
Upside: +218.78%
Oct 19, 2026
Reiterated: Sell
Price Target: $5
Current: $17.98
Upside: -72.19%
Oct 16, 2026
Reiterated: Buy
Price Target: $130
Current: $128.01
Upside: +1.55%
Oct 15, 2026
Reiterated: Buy
Price Target: $30
Current: $12.35
Upside: +142.91%
Oct 9, 2026
Reiterated: Buy
Price Target: $80
Current: $49.01
Upside: +63.23%
Oct 5, 2026
Reiterated: Buy
Price Target: $15
Current: $6.51
Upside: +130.41%
Oct 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.13
Upside: -
Oct 5, 2026
Reiterated: Buy
Price Target: $25
Current: $10.48
Upside: +138.55%
Sep 30, 2026
Reiterated: Buy
Price Target: $25
Current: $6.28
Upside: +298.09%
Sep 22, 2026
Reiterated: Buy
Price Target: $30 → $29
Current: $20.42
Upside: +42.02%
Sep 10, 2026
Reiterated: Hold
Price Target: $60
Current: $55.75
Upside: +7.62%
Sep 10, 2026
Reiterated: Buy
Price Target: kr 575.00
Current: kr 459.00
Upside: +25.27%
Sep 9, 2026
Reiterated: Buy
Price Target: $25
Current: $11.26
Upside: +122.02%
Sep 3, 2026
Reiterated: Buy
Price Target: $60
Current: $15.60
Upside: +284.62%
Aug 14, 2026
Reiterated: Buy
Price Target: $20
Current: $9.18
Upside: +117.86%
Aug 14, 2026
Reiterated: Buy
Price Target: $25
Current: $8.05
Upside: +210.56%
Aug 13, 2026
Reiterated: Buy
Price Target: $5
Current: $1.42
Upside: +252.11%
Aug 12, 2026
Reiterated: Buy
Price Target: $70 → $65
Current: $23.54
Upside: +176.13%
Aug 11, 2026
Reiterated: Buy
Price Target: $45
Current: $21.26
Upside: +111.67%
Aug 6, 2026
Reiterated: Buy
Price Target: $5
Current: $2.40
Upside: +108.33%
May 11, 2026
Reiterated: Buy
Price Target: $17 → $11
Current: $2.23
Upside: +394.38%
Jan 13, 2026
Reiterated: Buy
Price Target: $13 → $10
Current: $2.70
Upside: +270.37%
Jan 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $5.57
Upside: -
Oct 24, 2025
Reiterated: Buy
Price Target: $4
Current: $2.41
Upside: n/a
Oct 22, 2025
Reiterated: Buy
Price Target: $7
Current: $0.7674
Upside: n/a
Aug 19, 2025
Reiterated: Hold
Price Target: $3 → $2
Current: $3.56
Upside: n/a
Aug 11, 2025
Initiated Coverage: Buy
Price Target: $25
Current: $6.07
Upside: n/a
Apr 30, 2025
Rated: Hold
Price Target: n/a
Current: $16.65
Upside: n/a
Apr 4, 2025
Rated: Hold
Price Target: n/a
Current: $0.0003
Upside: n/a
Apr 3, 2025
Reiterated: Buy
Price Target: $9
Current: $0.6172
Upside: n/a
Mar 21, 2025
Reiterated: Buy
Price Target: $15
Current: $4.31
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $15
Current: $2.48
Upside: n/a